Document

Filter documents

pdf icon

Joint statement on ‘Abortion reversal’: RCOG, FSRH, RCM & BSACP

File size: 613kb | Date: 6 July 2022 | FSRH Statement - PDF

Joint statement on ‘Abortion reversal’ by the Royal College of Obstetricians and Gynaecologists (RCOG), The Faculty of Sexual and Reproductive Healthcare (FSRH), the Royal College of Midwives (RCM) and the British Society of Abortion Care Providers (BSACP)

pdf icon

FSRH CEU Statement on Nexplanon® Insertion Site 15 January 2020

File size: 327kb | Date: 15 January 2020 | Clinical Statements - PDF

This CEU Statement provides guidance to healthcare professionals in response to a letter circulated by MSD (manufacturer of Nexplanon®) to healthcare professionals in the UK about updated guidance regarding the recommended Nexplanon® insertion site.

pdf icon

APPG SRH Access to Contraception Inquiry - 2022 progress report

File size: 304kb | Date: 26 September 2022 | FSRH Policy and External Affairs - PDF

This report of the All Party Parliamentary Group on Sexual and Reproductive Health in the UK sets out a progress update against the recommendations of the Group's 2020 report on Access to Contraception, further to the publication of the Government's Women's Health Strategy.

pdf icon

Implementing the RCPCH guidance “Safeguarding guidance for children and young people under 18 accessing early medical abortion services” - Advice for Providers, Commissioners and Regulators.

File size: 252kb | Date: 23 September 2022 | FSRH Policy and External Affairs - PDF

This an advice document for providers, commissioners and regulators on implementing the RCPCH guidance “Safeguarding guidance for children and young people under 18 accessing early medical abortion services” (published in August 2022). It is endorsed by BSACP, FSRH and RCOG.

pdf icon

FSRH CEU Guidance: Progestogen-only Pills Quick Reference Summary (August 2022)

File size: 482kb | Date: 23 August 2022 | Current Clinical Guidance - PDF

This summary has been written as a quick reference guide to help busy clinicians to give clear, safe advice on progestogen-only contraceptive pills. Please refer to the full 2022 FSRH Progestogen-only Pills Clinical Guideline for further information and supporting evidence for this advice. This document is written for FSRH members and requires you to log in to access it.

pdf icon

FSRH Guideline: Progestogen-only Pills (August 2022) (Evidence relocated)

File size: 1623kb | Date: 23 August 2022 | Current Clinical Guidance - PDF

This guideline provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only contraceptive pills. It is intended for any healthcare professional or health service providing contraceptive care in the UK. In this version of the POP Guideline, the supporting evidence for the recommendations has been removed from the main text and located in an appendix for ease of reading. This document is written for FSRH members and requires you to log in to access it.